Bhavnani, Darlene
James, Emily R.
Johnson, Kaitlyn E.
Beaudenon-Huibregtse, Sylvie
Chang, Patrick
Rathouz, Paul J.
Weldon, Minda
Matouschek, Andreas
Young, Amy E.
Funding for this research was provided by:
Dell Medical School, University of Texas at Austin
National Institutes of Health (R01 AI151176)
Centers for Disease Control and Prevention (U01IP001136)
Article History
Received: 18 November 2021
Accepted: 29 July 2022
First Online: 5 August 2022
Declarations
:
: Research was performed in accordance with the Declaration of Helsinki.The University of Texas at Austin’s Institutional Review Board determined that the proposed activity is not research involving human subjects as defined by United States Department of Health and Human Services and the United States Food and Drug Administration regulations. The activity was determined to be non-Human subjects research and as a result, IRB review and approval by this organization is not required. Data were collected for the purpose of public health response and therefore, informed consent was not obtained. The dataset used for this research was de-identified.
: Not applicable.
: The authors declare that they have no competing interests.